Identification and functional analysis of fourteen NR5A1 variants in patients with the 46 XY disorders of sex development.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 Nov 2020
Historique:
received: 17 02 2020
revised: 21 06 2020
accepted: 25 07 2020
pubmed: 2 8 2020
medline: 2 10 2020
entrez: 2 8 2020
Statut: ppublish

Résumé

Human sex determination and differentiation is a complex process, during which NR5A1 plays a central role via the transcriptional regulation of key modulators involved in steroidogenesis. Approximately 8-15% of 46,XY DSD are caused by variants in the NR5A1 gene. Therefore, screening for variants in the NR5A1 gene was performed in a Chinese cohort of sixty-two 46,XY DSD patients with no AR or SRD5A2 variants via next-generation sequencing (NGS). Fourteen variants in the NR5A1 gene were identified in 16 patients from 14 unrelated families, including nine novel variants. These variants included eight heterozygote missense variants, two heterozygote frameshift variants, two heterozygote nonsense variants, one heterozygote nonframeshift deletion-insertion variant, and one homozygous missense variant. Functional assays showed that the transcriptional activity of the 11 variants was significantly reduced. In this study, 11 NR5A1 pathogenic variants were identified. These novel variants further expand the existing spectrum of the NR5A1 variants associated with 46,XY DSD, which will, in turn, assist in the molecular diagnosis of DSD.

Identifiants

pubmed: 32738419
pii: S0378-1119(20)30673-9
doi: 10.1016/j.gene.2020.145004
pii:
doi:

Substances chimiques

NR5A1 protein, human 0
Steroidogenic Factor 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145004

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Xiaoxue Na (X)

The Key Laboratory for Human Disease Gene Study of Sichuan Province, Prenatal Diagnosis Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China , Chengdu, Sichuan, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.

Yu Mao (Y)

Department of Pediatric Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.

Yunman Tang (Y)

Department of Pediatric Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.

Wei Jiang (W)

The Key Laboratory for Human Disease Gene Study of Sichuan Province, Prenatal Diagnosis Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China , Chengdu, Sichuan, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.

Jing Yu (J)

Medical Technology College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, PR China.

Li Cao (L)

Medical Technology College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, PR China.

Jiyun Yang (J)

The Key Laboratory for Human Disease Gene Study of Sichuan Province, Prenatal Diagnosis Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China , Chengdu, Sichuan, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China. Electronic address: yangjiyun@yeah.net.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH